Clinical trial

Actium-225-Prostate Specific Membrane Antigen Imaging & Therapy

NCT05902247

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-12-29

PhasePHASE1

Study timeline

Study start (actual)2021-12-29Date precision: day

Registry last updated2023-06-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Neoplasms, Castration-Resistantunresolved

Interventions

Radionuclide TherapyRADIATION

Sponsors & collaborators

Erasmus Medical Centerlead sponsor

Dutch Cancer Societycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05902247 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.